EMA considerations on COVID-19 vaccine approval - Scientific guideline
HumanCOVID-19Vaccines
Portuguese is available via eTranslation, the European Commission's machine translation service.
Translate to Portuguese | Important information about machine translation
This document provides guidance for developers of potential COVID-19 vaccines on the clinical evidence to include in marketing authorisation applications.
Keywords: COVID-19, SARS-CoV-2, vaccine, clinical requirements, clinical efficacy, clinical safety